Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Depressive Symptoms Linked to Motoric Cognitive Risk

May 5, 2026
Continue Reading
depressive-symptoms-linked-to-motoric-cognitive-risk
Posted inBiotechnology

Predicting Coronary Artery Aneurysms in Kawasaki Disease

May 5, 2026
Continue Reading
predicting-coronary-artery-aneurysms-in-kawasaki-disease
Posted inBiotechnology

Breakthrough Study Advances Personalized Treatment for Parkinson’s Disease

May 5, 2026
Continue Reading
breakthrough-study-advances-personalized-treatment-for-parkinson’s-disease
Posted inBiotechnology

School Fitness Testing: Challenges and New Opportunities

May 5, 2026
Continue Reading
school-fitness-testing:-challenges-and-new-opportunities
Posted inBiotechnology

ZNF473 Drives Colorectal Cancer, Boosts Chemoresistance

May 5, 2026
Continue Reading
znf473-drives-colorectal-cancer,-boosts-chemoresistance
Posted inBiotechnology

All-Metal Biodegradable Microrobots Set to Revolutionize Drug Delivery and Biopsy Techniques

May 5, 2026
Continue Reading
all-metal-biodegradable-microrobots-set-to-revolutionize-drug-delivery-and-biopsy-techniques
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

novo-holdings-leads-siteone’s-$100m-series-c-for-non-opioid-pain-treatments
Posted inBiotechnology

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

December 17, 2024
SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral…
Read More
ketamine-keeps-zebrafish-from-giving-up-by-overstimulating-astroglia
Posted inGenetics

Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia

December 17, 2024
The anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how…
Read More
bd,-babson-diagnostics-expand-fingertip-blood-draws-to-urgent-care-clinics,-doctors’-offices
Posted inMedical Technology

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

December 17, 2024
Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available…
Read More
dexcom-taps-generative-ai-lifestyle-tips-for-its-stelo-glucose-sensor
Posted inMedical Technology

Dexcom taps generative AI lifestyle tips for its Stelo glucose sensor

December 17, 2024
Dexcom has launched a generative AI platform aimed at providing personalized lifestyle tips to the users of its over-the-counter wearable…
Read More
sanofi,-teva-look-to-‘next-frontier’-in-ibd-treatment-after-tl1a-antibody-hits-mark-in-midstage-trial
Posted inBiotechnology

Sanofi, Teva look to ‘next frontier’ in IBD treatment after TL1A antibody hits mark in midstage trial

December 17, 2024
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and Teva…
Read More
biomea’s-diabetes-drug-improves-glucose-control-3-months-after-fda-hold-lifted
Posted inBiotechnology

Biomea’s diabetes drug improves glucose control 3 months after FDA hold lifted

December 17, 2024
Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in…
Read More
cash-strapped-portage-finds-hope-in-sale-of-lead-asset,-subsidiary-to-immunova
Posted inBiotechnology

Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova

December 17, 2024
After spending most of the year hunting for options to stay afloat, cash-strapped Portage Biotech appears to have found salvation…
Read More
fresh-off-$120m-raise,-ai-powered-terray-is-teaming-up-with-gilead-in-multi-pronged-r&d-pact
Posted inBiotechnology

Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact

December 17, 2024
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy…
Read More
fierce-biotech’s-top-10-editor’s-picks-for-2024
Posted inBiotechnology

Fierce Biotech’s top 10 editor’s picks for 2024

December 17, 2024
The year kicked off with a flurry of dealmaking at the J.P. Morgan Healthcare Conference in January, and the pace…
Read More
merck-drops-tigit-asset-and-lag-3-program,-discontinuing-several-phase-3-trials
Posted inBiotechnology

Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials

December 16, 2024
Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline…
Read More

Posts pagination

Previous page 1 … 1,774 1,775 1,776 1,777 1,778 … 1,784 Next page
You May Have Missed
nuvalent-teams-up-with-guardant-health-for-companion-diagnostics
Posted inMedical Technology

Nuvalent teams up with Guardant Health for companion diagnostics

genomics-inks-partnership-deal-with-greywolf-to-assess-gene-datasets
Posted inMedical Technology

Genomics inks partnership deal with Greywolf to assess gene datasets

labcorp-raises-full-year-guidance,-boosted-by-diagnostics,-lab-services
Posted inMedical Technology

Labcorp raises full-year guidance, boosted by diagnostics, lab services

caredx-expands-into-cancer-testing-with-$260m-naveris-buy
Posted inMedical Technology

CareDx expands into cancer testing with $260M Naveris buy

Privacy Policy    Terms

Scroll to Top